Evidence map›Paper›PMID 41751784›Full record

ArticleInternational journal of molecular sciences2026

Synthesis and Characterization of Mg-Doped CuO Nanoparticles and Their Enhanced Anticancer Efficacy Against HepG2 Liver Cancer Cells.

Chanachon Supha, Ramzan Ahmed, Vichugorn Wattayagorn, Sirikanjana Thongmee, Pramote Chumnanpuen

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chanachon SuphaDepartment of Zoology, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.
Ramzan AhmedDepartment of Physics, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.ORCID 0000-0003-3757-4764
Vichugorn WattayagornDepartment of Biochemistry, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.
Sirikanjana ThongmeeDepartment of Physics, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.ORCID 0000-0001-8294-9997
Pramote ChumnanpuenDepartment of Zoology, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.ORCID 0000-0003-3072-1733

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rising global incidence of hepatocellular carcinoma demands innovative therapeutic strategies. This study explores the enhanced anticancer potential of magnesium-doped copper oxide (Mg-doped CuO) nanoparticles, which were synthesized to improve upon the properties of undoped CuO nanoparticles. Mg-doped CuO nanoparticles with doping concentrations ranging from 1% to 5% were prepared using the co-precipitation method and thoroughly characterized by SEM, EDS, and FTIR. Their biological activity was evaluated against HepG2 liver cancer cells and normal human fibroblast cells. The MTT assay demonstrated a significant, concentration-dependent increase in cytotoxicity for Mg-doped CuO nanoparticles compared to undoped CuO, with the 3% Mg-doped CuO formulation showing the greatest potency (IC

Indexed as

Antineoplastic AgentsCopperLiver NeoplasmsMagnesiumMetal NanoparticlesApoptosisCarcinoma, HepatocellularHep G2 CellsHumansAntineoplastic AgentsCoppercupric oxideMagnesiumapoptosiscell cycle arresthepatocellular carcinomaMg-doped CuO nanoparticlesselective cytotoxicity

Identifiers

PMID41751784
PMCPMC12940181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.